论文部分内容阅读
近年来,药品购销中的“回扣”之风,在一些地方愈演愈烈。名目繁多的药品“回扣”令人咋舌,危害甚大,亟待整顿并规范管理。 药品回扣暗流浊涌 灰色交易的性质决定了药品回扣的方式是遮遮掩掩。时下一股暗流浊涌的药品回扣,肆无忌惮地摧毁着药品正常经销大堤。 报载,西北地区某市纪委、监察局先后收到8封群众来信,举报该市人民医院有关人员在采购药品和医疗设备中有收受贿赂的问题。核查中发现,该院两年共采购药品4191万元,对外采购药品涉及112个单位。按常规从内地采购药品有7％的折扣,从新疆采购药品有4％的折扣,但这些都没在帐面上反映,监察局首先查明,该院设备科在采购先峰5号、6号针剂的过程中,收受回扣5700元。还有该院药剂科主任等人私下收受
In recent years, the “rebate” style in drug purchases and sales has intensified in some places. The “rebate” for a wide range of drugs is staggering and very harmful. It urgently needs to be rectified and standardized. Drug Rebate Underflow The nature of the gray transaction determines the way drug rebates are concealed. At the same time, there was an undercurrent drug rebate that unscrupulously destroyed the normal distribution of drugs. According to the report, the Commission for Discipline Inspection and the Supervision Bureau of a city in the Northwestern region received letters from eight people and reported that people in the People’s Hospital of the city had received bribes in the procurement of medicines and medical equipment. During the inspection, it was discovered that the hospital purchased a total of 41.91 million yuan of medicines for two years, and the procurement of drugs to the outside involved 112 units. There is a 7% discount on the purchase of medicines from the Mainland on a regular basis, and a 4% discount on the purchase of medicines from Xinjiang. However, these are not reflected on the books. The Inspectorate first ascertained that the equipment division of the hospital was on the procuring peaks 5 and 6. In the process of injection, 5,700 yuan was accepted for rebate. In addition, the director of the pharmacy department of the hospital received privately